Carducci MA - Search Results

1

TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.

Denmeade SR, Wang H, Agarwal N, Smith DC, Schweizer MT, Stein MN, Assikis V, Twardowski PW, Flaig TW, Szmulewitz RZ, Holzbeierlein JM, Hauke RJ, Sonpavde G, Garcia JA, Hussain A, Sartor O, Mao S, Cao H, Fu W, Wang T, Abdallah R, Lim SJ, Bolejack V, Paller CJ, Carducci MA, Markowski MC, Eisenberger MA, Antonarakis ES. Denmeade SR, et al. Among authors: carducci ma. J Clin Oncol. 2021 Apr 20;39(12):1371-1382. doi: 10.1200/JCO.20.02759. Epub 2021 Feb 22. J Clin Oncol. 2021. PMID: 33617303 Free PMC article. Clinical Trial.

2

Interleukin-6: a candidate mediator of human prostate cancer morbidity.

Twillie DA, Eisenberger MA, Carducci MA, Hseih WS, Kim WY, Simons JW. Twillie DA, et al. Among authors: carducci ma. Urology. 1995 Mar;45(3):542-9. doi: 10.1016/S0090-4295(99)80034-X. Urology. 1995. PMID: 7879350

3

Prostate cancer treatment strategies based on tumor-specific biological principles: future directions.

Carducci MA, DeWeese TL, Nelson WG, Simons JW, Sinibaldi V, Eisenberger MA. Carducci MA, et al. Semin Oncol. 1996 Dec;23(6 Suppl 14):56-62. Semin Oncol. 1996. PMID: 8996587 Review.

4

Prostate-specific antigen and other markers of therapeutic response.

Carducci MA, DeWeese TL, Nelson JB. Carducci MA, et al. Urol Clin North Am. 1999 May;26(2):291-302, viii. doi: 10.1016/s0094-0143(05)70069-0. Urol Clin North Am. 1999. PMID: 10361552 Free article. Review.

5

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Wilding G, et al. Bubley GJ, et al. J Clin Oncol. 1999 Nov;17(11):3461-7. doi: 10.1200/JCO.1999.17.11.3461. J Clin Oncol. 1999. PMID: 10550143

6

Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer.

Sinibaldi VJ, Carducci M, Laufer M, Eisenberger M. Sinibaldi VJ, et al. Semin Oncol. 1999 Oct;26(5 Suppl 17):45-8. Semin Oncol. 1999. PMID: 10604269 Clinical Trial.

7

Management of patients with rising prostate-specific antigen after radical prostatectomy.

Laufer M, Pound CR, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. Urology. 2000 Mar;55(3):309-15. doi: 10.1016/s0090-4295(99)00465-3. Urology. 2000. PMID: 10699599 Review. No abstract available.

8

Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer.

Laufer M, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. Urology. 1999 Oct;54(4):745. doi: 10.1016/s0090-4295(99)00268-x. Urology. 1999. PMID: 10754148 Free article.

9

Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.

Kaufman D, Raghavan D, Carducci M, Levine EG, Murphy B, Aisner J, Kuzel T, Nicol S, Oh W, Stadler W. Kaufman D, et al. J Clin Oncol. 2000 May;18(9):1921-7. doi: 10.1200/JCO.2000.18.9.1921. J Clin Oncol. 2000. PMID: 10784633 Clinical Trial.

10

Complete androgen blockade for prostate cancer: what went wrong?

Laufer M, Denmeade SR, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. J Urol. 2000 Jul;164(1):3-9. J Urol. 2000. PMID: 10840412 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

426 results

Search Page